Edoxaban Drug Interactions

Brand name
  • Savaysa
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated Details about this page

About Edoxaban

Edoxaban is a blood thinner that prevents strokes and blood clots in people with irregular heartbeat or those recovering from blood clots.

Read the full Edoxaban drug information page 

The Bottom Line on Edoxaban

Ibuprofen is the one to know about if you take edoxaban: put together, the two can raise your risk of bleeding, and that pairing is rated major. Edoxaban is a blood thinner that helps prevent strokes and clots if you have an irregular heartbeat or are recovering from a clot.

Edoxaban has a lot to keep track of, with more documented interactions than most medicines, and most of them are rated serious. Two pairs are rated contraindicated. Bleeding is the problem that comes up most, and several common antidepressants, including sertraline and fluoxetine, share that concern.

Supplements, herbs and foods are part of the picture too, with roughly 220 rated interactions, though only two are rated major. Before buying any new supplement or over-the-counter product, ask the pharmacist at the counter.

From the HelloPharmacist Editorial Team Written with AI from this page's interaction records · How we build these pages · How we use AI · Our editorial policy

Check Edoxaban Against Another Drug or Supplement

Type a drug, a brand name or a supplement. We check it against every documented edoxaban interaction, supplements and herbs included.

    What Could Happen When Edoxaban Interacts

    What the 300 documented edoxaban interaction records say could happen, grouped by the problem each one names. Tap a bar to see those drugs.

    This chart covers drug interactions only. Interactions with supplements and herbs are studied far less, so they are not counted here; they have their own section below. One interaction can name more than one problem, so the numbers add up to more than 300.

    Edoxaban Interactions by Severity

    Edoxaban With Supplements and Herbs

    Supplements can interact with edoxaban too. The Natural Medicines database, which we license, rates 223 of them for an interaction with edoxaban, and every one of the 1,330 supplements and herbs we cover has a page on taking it with edoxaban.

    Rated for an Interaction With Edoxaban

    Every Supplement and Herb With Edoxaban, A to Z1,330 pages

    Each one opens its page on taking it with edoxaban, whether or not an interaction is rated.

    Browse every supplement and herb 

    Check a supplement bottle against edoxaban with our drug–supplement interaction checker, or scan its label.

    How Drug Interactions Work New to drug interactions? Six short figures, about a minute, show what can happen when Edoxaban meets another medicine: a level that rises or falls, or effects that add up. See how it works 

    Look Up Another Drug

    Still Have Questions About Edoxaban?

    Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

    About This Library

    Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

    What Each Rating Means

    Severity Levels

    • Contraindicated These should generally not be used together.
    • Major Potentially serious — often needs a change or close monitoring.
    • Moderate Can be significant — usually manageable with monitoring.
    • Minor Usually limited clinical impact.
    Back to the answer

    The References Behind Edoxaban’s Interactions

    The 283 sources our edoxaban interaction records cite: clinical studies, case reports and FDA prescribing information. Each pair's page lists the ones it rests on, numbered in its text, and a source link is one we checked against PubMed or Crossref. How we check them →

    1. Product Information: SAVAYSA(TM) oral tablets, edoxaban oral tablets. Daiichi Sankyo, Inc. (per FDA), Parsippany, NJ, 2015. DailyMed 
    2. Angiolillo DJ, Bhatt DL, Cannon CP, et al: Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a North American perspective: 2021 update. Circulation 2021; 143(6):583-596. PubMed 
    3. Hindricks G, Potpara T, Dagres N, et al: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021; 42(5):373-498.
    4. Joglar JA, Chung MK, Armbruster AL, et al: 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation 2024; 149(1):e1-e156.
    5. Vranckx P, Valgimigli M, Eckardt L, et al: Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial. Lancet 2019; 394(10206):1335-1343. PubMed 
    6. Key NS, Khorana AA, Kuderer NM, et al: Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol 2020; 38(5):496-520. DOI 
    7. Writing Committee Members, Creager MA, Barnes GD, et al: 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the evaluation and management of acute pulmonary embolism in adults: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2026; Epub:Epub. PubMed 
    8. Stevens SM, Woller SC, Kreuziger LB, et al: Antithrombotic therapy for VTE disease: second update of the CHEST Guideline and Expert Panel Report. Chest 2021; 160(6):e545-e608. PubMed 
    9. Key NS, Khorana AA, Kuderer NM, et al: Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Guideline Update. J Clin Oncol 2023; Epub:Epub.
    10. Raskob GE, van Es N, Verhamme P, et al: Edoxaban for the treatment of cancer-associated venous thromboembolism. N Engl J Med 2018; 378(7):615-624. PubMed 

    Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.